Cargando…
Glucagon regulates lipolysis and fatty acid oxidation through inositol triphosphate receptor 1 in the liver
Glucagon promotes hepatic glucose production, lipolysis and amino acid catabolism. Inhibition of glucagon activity, or glucagon resistance, not only lowers blood glucose levels, but also induces non‐alcoholic fatty liver disease and hyperaminoacidemia.[Image: see text]
Autor principal: | Hayashi, Yoshitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779274/ https://www.ncbi.nlm.nih.gov/pubmed/32506830 http://dx.doi.org/10.1111/jdi.13315 |
Ejemplares similares
-
CaMKII regulation of cardiac ryanodine receptors and inositol triphosphate receptors
por: Camors, Emmanuel, et al.
Publicado: (2014) -
Glucagon receptor signaling at white adipose tissue does not regulate lipolysis
por: Vasileva, Anastasiia, et al.
Publicado: (2022) -
Adipose tissue lipolysis, plasma fatty acids, and glucose homeostasis in people with obesity: New pieces that help solve the puzzle
por: Koh, Han-Chow E., et al.
Publicado: (2021) -
Antibodies to inositol 1,4,5-triphosphate receptor 1 in patients with cerebellar disease
por: Fouka, Penelope, et al.
Publicado: (2016) -
Role of Type 1 Inositol 1,4,5-triphosphate Receptors in Mammalian
Oocytes
por: Yoon, Sook Young
Publicado: (2019)